The cross-talk between ROS and p38MAPKα in the Ex Vivo expanded human umbilical cord blood CD133⁺ cells

Abstract

This study investigated the correlation between and compared the effects of reactive oxygen species (ROS) and p38 mitogen-activated protein kinase α (p38MAPKα) in the ex vivo expanded umbilical cord blood (hUCB) CD133⁺ cells. hUCB CD133⁺ cells were cultured in the hematopoietic stem cells (HSCs) culture medium with N-acetylcysteine (NAC, an anti-oxidant), p38MAPKα-specific inhibitor (SB203580) or their combination. The levels of ROS and expression of phosphorylated p38MAPKα (p-p38) in CD133⁺ cells were flow cytometrically detected. The efficacy of ex vivo expansion was evaluated by the density of CD133⁺ cell sub-group colony-forming cells (CFC) and cobblestone area-forming cells (CAFC) assay. Our results showed decreased ROS levels in NAC, SB203580, and their combination treatment groups were almost 37%, 48%, and 85%, respectively. Furthermore, SB203580 abrogated the activation of p38MAPKα more obviously than NAC. Moreover, the CD133⁺ cells in SB203580 treatment group had a 21.93±1.36-fold increase, and 14.50±1.19-fold increase in NAC treatment group, but only 10.13±0.57-fold increase in control group. In addition, SB203580 treatment led a higher level increase in the number of CFU and CAFC than NAC did. These findings suggested that, in expanded CD133⁺ cells, ROS activates p38MAPKα, which, in turn, induces ROS production, and p38MAPKα might be the most suitable regulator in ROS-p38MAPKα pathway for the promotion of HSCs ex vivo expansion.

Keywords

p38 mitogen-activated protein kinase α / reactive oxygen species / human cord blood CD133⁺ cells / hematopoiesis / ex vivo expansion

References

[1] KellyS.S., SolaC.B., de LimaM., et al.. Ex vivo expansion of cord blood. Bone Marrow Transplant, 2009, 44(10): 673-681

[2] McNieceI.K., Almeida-PoradaG., ShpallE.J., et al.. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol, 2002, 30(6): 612-616

[3] NollT., JelinekN., SchmidS., et al.. Cultivation of hematopoietic stem and progenitor cells: biochemical engineering aspects. Adv Biochem Eng Biotechnol, 2002, 74: 111-128

[4] ItoK., HiraoA., AraiF., et al.. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med, 2006, 12(4): 446-451

[5] GeestC.R., CofferP.J.. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol, 2009, 86(2): 237-250

[6] ZhouL., OpalinskaJ., VermaA.. p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle, 2007, 6(5): 534-537

[7] MiyamotoK., ArakiK.Y., NakaK., et al.. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell, 2007, 1(1): 101-112

[8] HermitteF., BrunetD.L.G.P., BellocF., et al.. Very low O₂ concentration (0.1%) favors G₀ return of dividing CD34⁺ cells. Stem Cells, 2006, 24(1): 65-73

[9] IvanovicZ., HermitteF., BrunetD.L.G.P., et al.. Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O₂ concentration (3%). Stem Cells, 2004, 22(5): 716-724

[10] WangY., SchulteB.A., LaRueA.C., et al.. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood, 2006, 107(1): 358-366

[11] WangY., KellnerJ., LiuL., et al.. Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion. Stem Cells Dev, 2011, 20(7): 1143-1152

[12] ZhengW., WanY., MaX., et al.. Isolation of cultured endothelial progenitor cells in vitro from PBMCs and CD133(+) enriched cells. J Huazhong Univ Sci Technolog [Med Sci], 2010, 30(1): 18-24

[13] ArakiH., MahmudN., MilhemM., et al.. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp Hematol, 2006, 34(2): 140-149

[14] PloemacherR.E., van der SluijsJ.P., VoermanJ.S., et al.. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood, 1989, 74(8): 2755-2763

[15] TothovaZ., KolliparaR., HuntlyB.J., et al.. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell, 2007, 128(2): 325-339

[16] GoffJ.P., ShieldsD.S., GreenbergerJ.S.. Influence of cytokines on the growth kinetics and immunophenotype of daughter cells resulting from the first division of single CD34(+)Thy-1(+)lin- cells. Blood, 1998, 92(11): 4098-4107

[17] WangY., LiuL., PazhanisamyS.K., et al.. Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic Biol Med, 2010, 48(2): 348-356

[18] MengA., WangY., Van ZantG., et al.. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res, 2003, 63(17): 5414-5419

[19] HongE.H., LeeS.J., KimJ.S., et al.. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J Biol Chem, 2010, 285(2): 1283-1295

[20] ItoK., HiraoA., AraiF., et al.. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature, 2004, 431(7011): 997-1002

[21] JangY.Y., SharkisS.J.. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood, 2007, 110(8): 3056-3063

[22] IiyamaM., KakihanaK., KurosuT., et al.. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal, 2006, 18(2): 174-182

[23] KyriakisJ.M., AvruchJ.. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev, 2001, 81(2): 807-869

[24] IwasaH., HanJ., IshikawaF.. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells, 2003, 8(2): 131-144

[25] JuntillaM.M., PatilV.D., CalamitoM., et al.. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood, 2010, 115(20): 4030-4038